This report studies the CRISPR And CRISPR-Associated (Cas) Genes market. Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid. The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea. Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down. By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline. This report aims to provide a comprehensive presentation of the global market for CRISPR And CRISPR-Associated Genes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR And CRISPR-Associated Genes. This report contains market size and forecasts of CRISPR And CRISPR-Associated Genes in global, including the following market information: Global CRISPR And CRISPR-Associated Genes Market Revenue, 2018-2023, 2024-2029, ($ millions) Global top five companies in 2022 (%) The global CRISPR And CRISPR-Associated Genes market was valued at US$ 1424.5 million in 2022 and is projected to reach US$ 1794 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares. CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CRISPR And CRISPR-Associated Genes companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global CRISPR And CRISPR-Associated Genes Market, by Type, 2018-2023, 2024-2029 ($ millions) Global CRISPR And CRISPR-Associated Genes Market Segment Percentages, by Type, 2022 (%) Genome Editing Genetic Engineering GRNA Database/Gene Librar CRISPR Plasmid Human Stem Cells Genetically Modified Organisms/Crops Cell Line Engineering Global CRISPR And CRISPR-Associated Genes Market, by Application, 2018-2023, 2024-2029 ($ millions) Global CRISPR And CRISPR-Associated Genes Market Segment Percentages, by Application, 2022 (%) Biotechnology Companies Pharmaceutical Companies Academic Institutes Research and Development Institutes Global CRISPR And CRISPR-Associated Genes Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) Global CRISPR And CRISPR-Associated Genes Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies CRISPR And CRISPR-Associated Genes revenues in global market, 2018-2023 (estimated), ($ millions) Key companies CRISPR And CRISPR-Associated Genes revenues share in global market, 2022 (%) Further, the report presents profiles of competitors in the market, key players include: Thermo Fisher Scientific Editas Medicine Caribou Biosciences CRISPR therapeutics Intellia therapeutics, Inc. Cellectis Horizon Discovery Plc Sigma Aldrich Precision Biosciences Genscript Sangamo Biosciences Inc. Lonza Group Limited Integrated DNA Technologies New England Biolabs Origene Technologies Outline of Major Chapters: Chapter 1: Introduces the definition of CRISPR And CRISPR-Associated Genes, market overview. Chapter 2: Global CRISPR And CRISPR-Associated Genes market size in revenue. Chapter 3: Detailed analysis of CRISPR And CRISPR-Associated Genes company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of CRISPR And CRISPR-Associated Genes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports 1.1 CRISPR And CRISPR-Associated Genes Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global CRISPR And CRISPR-Associated Genes Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 R